Roche Holding AG (RHHBF)
OTC
Closed
Aug 21, 2026
Day's Range
468.1052 wk Range
301.27Overview - RHHBF - Roche Holding AG
Key Statistics
Valuation
Enterprise Value
499.98B
P/E (Trailing)
‪24.39‬
P/E (Forward)
‪31.54‬
PEG Ratio
‪31.54‬
Price / Sales (TTM)
‪5.92‬
Price / Book
‪9.24‬
EV / EBITDA
‪16.71‬
Profitability
Profit Margin
‪19.60%‬
Operating Margin
‪36.20%‬
Return on Assets
‪13.50%‬
Return on Equity
‪38.10%‬
Ownership
Shares Outstanding
796.76M
Float
654.08M
Held by Insiders
‪72.31%‬
Held by Institutions
‪10.96%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪429.55‬
200-Day Avg
‪424.68‬
Dividends
Payout Ratio
‪63.93%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - RHHBF - Roche Holding AG
Peers - RHHBF - Roche Holding AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
Profile Summary - RHHBF - Roche Holding AG
About
Roche Holding AG is a Swiss multinational holding company and one of the world's largest biotech firms, overseeing the operations of F. Hoffmann-La Roche AG, a leading provider of pharmaceuticals and in-vitro diagnostics. Founded in 1896 and headquartered in Basel, it drives innovation across major disease areas…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
